Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Prestige Consumer Healthcare has acquired LaCorium Health, a healthcare services other business in New York, for $79,882.02. Prestige Consumer Healthcare acquisitions expand its healthcare services other footprint by adding LaCorium Health’s capabilities serving patients and providers in NY. The LaCorium Health acquisition supports Prestige’s strategic acquisition strategy within healthcare M&A and strengthens its add on acquisition approach. The healthcare deals NY transaction is an announced add on acquisition led by a strategic buyer, with deal size under $10M and expected integration as part of broader Prestige Consumer Healthcare acquisitions.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026